Literature DB >> 2111087

Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media.

C D Marchant1.   

Abstract

For many years Branhamella catarrhalis was regarded as a non-pathogenic inhabitant of the respiratory tract. This article outlines the spectrum of B. catarrhalis disease in childhood and the extent of the evidence for a pathogenic role of the organism. B. catarrhalis is a rare etiologic agent in septicemia, meningitis, and other systemic illness in both apparently normal and immunocompromised infants and children. It is an unusual cause of ophthalmia neonatorum, but can be confused with Neisseria gonorrhoeae. Whether or not B. catarrhalis is acquired from the birth canal in these cases has not been established. B. catarrhalis is most common as a respiratory tract pathogen in children, including pneumonia, bacterial tracheitis, sinusitis, and otitis media. Since it is difficult to rigorously document pathogenicity of any bacterium in bronchopulmonary infections in children, it is probable that the spectrum of B. catarrhalis disease is wider than that reported to date. The evidence for pathogenicity in acute otitis media is more extensive than for other infections. Otitis media due to B. catarrhalis is clinically similar to that due to other pathogens. B. catarrhalis can be isolated in pure culture from the middle ear exudate and persists if there is no antibacterial treatment. Gram-negative intracellular and extracellular diplococci can be seen on smears of the inflammatory exudate. There is preliminary evidence that there is an antibody response in B. catarrhalis otitis media. B. catarrhalis has emerged as an important and common pathogen in neonates, infants, and children.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111087     DOI: 10.1016/0002-9343(90)90255-c

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A B Brueggemann; G Pierce; T Hogan; H P Holley; A Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

2.  Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR.

Authors:  Oliver Greiner; Philip J R Day; Martin Altwegg; David Nadal
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.

Authors:  K Oishi; H Tanaka; F Sonoda; S Borann; K Ahmed; Y Utsunomiya; K Watanabe; T Nagatake; M Vaneechoutte; G Verschraegen; K Matsumoto
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

5.  Molecular epidemiological characterization of respiratory isolates of Moraxella catarrhalis in a pediatric intensive care unit.

Authors:  A G Matlow; D E Low; G Paret; S Jarrett; D Bohn; G Barker; J Boulanger; E L Ford-Jones
Journal:  Can J Infect Dis       Date:  1992-07

6.  Inactivation of the Moraxella catarrhalis superoxide dismutase SodA induces constitutive expression of iron-repressible outer membrane proteins.

Authors:  Nicole R Luke; Richard J Karalus; Anthony A Campagnari
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection.

Authors:  M G Morgan; H McKenzie; M C Enright; M Bain; F X Emmanuel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

9.  Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media.

Authors:  H Faden; J Hong; T Murphy
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Down-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillins.

Authors:  Marion Jetter; Violeta Spaniol; Rolf Troller; Christoph Aebi
Journal:  J Antimicrob Chemother       Date:  2010-08-27       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.